Skip to main content
Premium Trial:

Request an Annual Quote

Biolog Recently Wins $2M in NIH Grants; Firm to Further Develop Phenotype Microrrary

NEW YORK, Dec. 28 (GenomeWeb News) - Biolog has pocketed approximately $2 million through four recent grants from the US National Institutes of Health, according to the NIH.

 

The company is developing living mammalian cell arrays for drug-discovery and -development applications. The four new grants, which the NIH said are effective as of Dec. 26, include:

 

  • $920,940 for the detection of bioterrorism agents with [the company's phenotype microarray] technology;
  • $650,000 to develop the phenotype array for drug toxicity screening;
  • $276,981 to develop the array for analysis of "fastidious pathogens;" and
  • $123,238 to phenotype all the genes of S. cerevisae.
The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.